| Mr Martin F Dylla, LPN | |
|
12744 W Peck Pl, Butler, WI 53007-1808 | |
| (141) 441-6550 | |
| Not Available |
| Full Name | Mr Martin F Dylla |
|---|---|
| Gender | Male |
| Speciality | Licensed Practical Nurse |
| Location | 12744 W Peck Pl, Butler, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801955679 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 28605-031 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Martin F Dylla, LPN 12744 W Peck Pl, Butler, WI 53007-1808 Ph: (141) 441-6550 | Mr Martin F Dylla, LPN 12744 W Peck Pl, Butler, WI 53007-1808 Ph: (141) 441-6550 |
News Archive
Caspase-12 is a molecule with a death-wish. Found only in people of African descent, this protein shuts down our body's immune system, opening the door to potentially lethal infections. In a groundbreaking new study published in the prestigious journal Nature this week, the team that first discovered the role of caspase-12 in humans has now uncovered the mechanism by which it sabotages us, allowing researchers to develop methods to counter its damaging effects.
An online survey of men who have sex with men and their health service providers shows that the majority of respondents said most "gay men worldwide don't have access to HIV testing, counseling or free condoms and lubricant, a new study finds," according to a report by the Global Forum on MSM & HIV, HealthDay/Businessweek reports.
Hadasit Bio-Holdings a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced Thrombotech Ltd., a portfolio company which Hadasit holds a 24% stake in, received an IND approval from the Food and Drug Administration enabling the initiation of a Phase IIa clinical trial in the U.S.
University of North Carolina Lineberger Comprehensive Cancer Center researchers have identified a potential new treatment for brain cancer by learning from a rare condition that can cause microcephaly.
New Zealanders who were immunised against influenza last year are likely to have some protection against the current influenza viruses hitting schools around the country.
› Verified 7 days ago
Laura Ann Dolphin, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 12415 W Glendale Ave, Butler, WI 53007 Phone: 414-559-3653 |